MedTrace Logo

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV

NCT06126913 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2720

Last updated 2025-01-09

No results posted yet for this study

Summary

This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy (ART) delivery to people newly diagnosed with HIV in achieving HIV viral suppression.

Conditions

  • HIV Infections
  • Hiv

Interventions

OTHER

Community Antiretroviral Therapy

Newly diagnosed individuals (diagnosed in the prior 6 months) at intervention sites will be offered community ART delivery on a rolling basis during the enrollment window, initiating individuals into groups as close to their date of diagnosis as possible. Newly enrolled individuals will join existing community ART delivery groups, or when a new group is needed based on group size or geographic location, a new group will be formed.

Sponsors & Collaborators

Principal Investigators

  • Kelli N. O'Laughlin, MD, MPH · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06126913 on ClinicalTrials.gov